Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease

by Renske H. Olie, Paola E. J. van der Meijden, Henri M. H. Spronk, Rene van Oerle, Stale Barvik, Vernon V. S. Bonarjee, Hugo ten Cate, Dennis W. T. Nilsen
Published 2019-07-01